Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BR-TD-1001
- Development stage
- Phase 3
- Lead developer
- Boryung Biopharma
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
**BR-TD-1001** is an aluminum hydroxide-adsorbed, bivalent tetanus-diphtheria toxoid vaccine developed by Boryung Biopharma for booster immunization against tetanus and diphtheria. Each 0.5 mL dose contains tetanus toxoid and reduced-dose diphtheria toxoid; sodium chloride is included as an isotonic agent and aluminum hydroxide as an adsorbent adjuvant. It induces antigen-specific neutralizing antitoxin responses that protect against the toxin-mediated diseases caused by *Clostridium tetani* and *Corynebacterium diphtheriae*. In completed randomized Phase 3 testing in Korean children aged 10 to 12 years, BR-TD-1001 showed non-inferior immunogenicity to Td-pur and an acceptable safety profile. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC4635941/))
- Other names
- Td vaccine
02
Targets
BCR (Immunoglobulin G B Cell Receptor)
Beyond the preview
Go deeper on BR-TD-1001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BR-TD-1001.